CollPlant Biotechnologies (CLGN) Inventory Average (2018 - 2025)

CollPlant Biotechnologies (CLGN) has reported Inventory Average for 8 consecutive years, with $556500.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Inventory Average rose 24.5% year-over-year to $556500.0; the trailing twelve-month figure through Dec 2025 stood at $556500.0 (up 24.5% YoY), and the FY2025 full-year result was $506500.0, down 12.22% from the prior year.
• Inventory Average rose to $556500.0 in Q4 2025 per CLGN's latest filing, from $546500.0 in the prior quarter.
• Across five years, Inventory Average topped out at $1.7 million in Q2 2023 and bottomed at $446500.0 in Q3 2024.
• Historically, Inventory Average has averaged $1.0 million across 5 years, with a median of $1.1 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Inventory Average soared 36.8% in 2023, then tumbled 70.77% in 2024.
• Over 5 years, Inventory Average stood at $1.1 million in 2021, then increased by 14.5% to $1.3 million in 2022, then fell by 13.33% to $1.1 million in 2023, then tumbled by 59.68% to $447000.0 in 2024, then gained by 24.5% to $556500.0 in 2025.
• According to Business Quant data, Inventory Average over the past three periods registered $556500.0, $546500.0, and $447000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.